Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1972 Sep;51(9):2388–2398. doi: 10.1172/JCI107051

Studies on the relationship between plasma free fatty acids and growth hormone secretion in man

Hans-Jürgen Quabbe 1, Hans-Jürgen Bratzke 1, Ulrike Siegers 1, Kadip Elban 1
PMCID: PMC292406  PMID: 4639023

Abstract

The influence of plasma free fatty acid (FFA) concentration on the secretion of human growth hormone (HGH) was investigated. (a) FFA depression was produced by means of a nicotinic acid (NA) infusion for either 1 or 5 hr in the presence of glucose-induced hyperglycemia. Controls received only saline. (b) FFA depression was also produced by a 90 min NA infusion and then rapid FFA elevation by a lipid-plus-heparin (lipid) infusion. This procedure was compared with a similar NA infusion not followed by lipid. (c) FFA elevation was produced either by a lipid or by a norepinephrine (NE) infusion and then HGH secretion was stimulated by insulin-induced hypoglycemia. Each subject in this group received both the lipid and the NE infusion on seperate days as well as two control tests (insulin alone and NE alone).

Depression of FFA resulted in an increase of HGH with a lag period of approximately 2 hr. Maximal HGH rise after 1 hr NA infusion was 7.7±1.9 ng/ml and with 5 hr NA infusion 14.3±3.6 ng/ml (both significantly higher than during saline infusion, P < 0.025 and < 0.005 respectively) and occurred despite continuous hyperglycemia. Lipid infusion just before the expected HGH increase prevented the HGH response to FFA depression. HGH rise during insulin hypoglycemia (32.2±6.5 ng/ml) was significantly inhibited by prior FFA elevation whether achieved by lipid infusion (maximum HGH rise 11.4±1.6 ng/ml) or by NE infusion (maximum HGH rise 19.0±6.2 ng/ml).

The results are suggestive of a negative feedback loop between plasma FFA and HGH secretion, of importance for subacute rather than acute changes in the plasma FFA concentration. FFA lack itself seems to be the signal for HGH release despite the lag period between FFA decrease and HGH increase. Glucose and FFA can at least not fully replace each other in their respective influence on HGH release.

Full text

PDF
2388

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bazan N. G., Jr, de Bazan H. E., Kennedy W. G., Joel C. D. Regional distribution and rate of production of free fatty acids in rat brain. J Neurochem. 1971 Aug;18(8):1387–1393. doi: 10.1111/j.1471-4159.1971.tb00003.x. [DOI] [PubMed] [Google Scholar]
  2. Blackard W. G., Boylen C. T., Hinson T. C., Nelson N. C. Effect of lipid and ketone infusions on insulin-induced growth hormone elevations in rhesus monkeys. Endocrinology. 1969 Dec;85(6):1180–1185. doi: 10.1210/endo-85-6-1180. [DOI] [PubMed] [Google Scholar]
  3. Blackard W. G., Heidingsfelder S. A. Adrenergic receptor control mechanism for growth hormone secretion. J Clin Invest. 1968 Jun;47(6):1407–1414. doi: 10.1172/JCI105832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Blackard W. G., Heidingsfelder S. A. Effect of adrenergic receptor blackade on nicotinic acid-induced plasma FFA rebound. Metabolism. 1969 Mar;18(3):226–233. doi: 10.1016/0026-0495(69)90042-0. [DOI] [PubMed] [Google Scholar]
  5. Blackard W. G., Hubbell G. J. Stimulatory effect of exogenous catecholamines on plasma HGH concentrations in presence of beta adrenergic blockade. Metabolism. 1970 Jul;19(7):547–552. doi: 10.1016/0026-0495(70)90010-7. [DOI] [PubMed] [Google Scholar]
  6. Blackard W. G., Hull E. W., Lopez A. Effect of lipids on growth hormone secretion in humans. J Clin Invest. 1971 Jul;50(7):1439–1443. doi: 10.1172/JCI106627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. CARLSON L. A., ORO L. The effect of nicotinic acid on the plasma free fatty acid; demonstration of a metabolic type of sympathicolysis. Acta Med Scand. 1962 Dec;172:641–645. doi: 10.1111/j.0954-6820.1962.tb07203.x. [DOI] [PubMed] [Google Scholar]
  8. Cahill G. F., Jr, Herrera M. G., Morgan A. P., Soeldner J. S., Steinke J., Levy P. L., Reichard G. A., Jr, Kipnis D. M. Hormone-fuel interrelationships during fasting. J Clin Invest. 1966 Nov;45(11):1751–1769. doi: 10.1172/JCI105481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Carlson L. A., Fröberg S. O., Nye E. R. Acute effects of nicotinic acid on plasma, liver, heart and muscle lipids. Nicotinic acid in the rat. II. Acta Med Scand. 1966 Nov;180(5):571–579. doi: 10.1111/j.0954-6820.1966.tb02872.x. [DOI] [PubMed] [Google Scholar]
  10. DOLE V. P., MEINERTZ H. Microdetermination of long-chain fatty acids in plasma and tissues. J Biol Chem. 1960 Sep;235:2595–2599. [PubMed] [Google Scholar]
  11. Dhopeshwarkar G. A., Mead J. F. Fatty acid uptake by the brain. II. Incorporation of [I-14C] palmitic acid into the adult rat brain. Biochim Biophys Acta. 1969 Dec 17;187(4):461–467. [PubMed] [Google Scholar]
  12. GLICK S. M., ROTH J., YALOW R. S., BERSON S. A. THE REGULATION OF GROWTH HORMONE SECRETION. Recent Prog Horm Res. 1965;21:241–283. [PubMed] [Google Scholar]
  13. HUNTER W. M., GREENWOOD F. C. STUDIES ON THE SECRETION OF HUMAN-PITUITARY-GROWTH HORMONE. Br Med J. 1964 Mar 28;1(5386):804–807. doi: 10.1136/bmj.1.5386.804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hansen A. P. The effect of intravenous infusion of lipids on the exercise-induced serum growth hormone rise in normals and juvenile diabetics. Scand J Clin Lab Invest. 1971 Oct;28(2):207–212. doi: 10.3109/00365517109086901. [DOI] [PubMed] [Google Scholar]
  15. Hunter W. M., Fonseka C. C., Passmore R. The rôle of growth hormone in the mobilization of fuel for muscular exercise. Q J Exp Physiol Cogn Med Sci. 1965 Oct;50(4):406–416. doi: 10.1113/expphysiol.1965.sp001806. [DOI] [PubMed] [Google Scholar]
  16. Imura H., Kato Y., Ikeda M., Morimoto M., Yawata M. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man. J Clin Invest. 1971 May;50(5):1069–1079. doi: 10.1172/JCI106578. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Irie M., Tsushima T., Sakuma M. Effect of nicotinic acid administaation on plasma HGH, FFA and glucose in obese subjects and in hypopituitary patients. Metabolism. 1970 Nov;19(11):972–979. doi: 10.1016/0026-0495(70)90043-0. [DOI] [PubMed] [Google Scholar]
  18. LAURELL S. Turnover rate of unesterified fatty acids in human plasma. Acta Physiol Scand. 1957 Dec 7;41(2-3):158–167. doi: 10.1111/j.1748-1716.1957.tb01517.x. [DOI] [PubMed] [Google Scholar]
  19. Lunt G. G., Rowe C. E. The effect of cholinergic substances on the production of unesterified fatty acids in brain. Brain Res. 1971 Dec 10;35(1):215–220. doi: 10.1016/0006-8993(71)90606-8. [DOI] [PubMed] [Google Scholar]
  20. Massara F., Strumia E. Increase in plasma growth hormone concentration in man after infusion of adrenaline-propranolol. J Endocrinol. 1970 May;47(1):95–100. doi: 10.1677/joe.0.0470095. [DOI] [PubMed] [Google Scholar]
  21. Merimee T. J., Felig P., Marliss E., Fineberg S. E., Cahill G. G., Jr Glucose and lipid homeostasis in the absence of human growth hormone. J Clin Invest. 1971 Mar;50(3):574–582. doi: 10.1172/JCI106527. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Miettinen T. A., Taskinen M. R., Pelkonen R., Nikkilä E. A. Glucose tolerance and plasma insulin in man during acute and chronic administration of nicotinic acid. Acta Med Scand. 1969 Oct;186(4):247–253. doi: 10.1111/j.0954-6820.1969.tb01473.x. [DOI] [PubMed] [Google Scholar]
  23. Paul P., Issekutz B., Jr, Miller H. I. Interrelationship of free fatty acids and glucose metabolism in the dog. Am J Physiol. 1966 Dec;211(6):1313–1320. doi: 10.1152/ajplegacy.1966.211.6.1313. [DOI] [PubMed] [Google Scholar]
  24. Quabbe H. J. Radioimmunologische Bestimmung von Wachstumshormon im Plasma des Menschen. Z Klin Chem Klin Biochem. 1969 May;7(3):259–268. [PubMed] [Google Scholar]
  25. RABEN M. S., HOLLENBERG C. H. Effect of growth hormone on plasma fatty acids. J Clin Invest. 1959 Mar;38(3):484–488. doi: 10.1172/JCI103824. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. RABINOWITZ D., KLASSEN G. A., ZIERLER K. L. EFFECT OF HUMAN GROWTH HORMONE ON MUSCLE AND ADIPOSE TISSUE METABOLISM IN THE FOREARM OF MAN. J Clin Invest. 1965 Jan;44:51–61. doi: 10.1172/JCI105126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. ROBINSON D. S., HARRIS P. M. The production of lipolytic activity in the circulation of the hind limb in response to heparin. Q J Exp Physiol Cogn Med Sci. 1959 Jan;44(1):80–90. doi: 10.1113/expphysiol.1959.sp001378. [DOI] [PubMed] [Google Scholar]
  28. Schalch D. S., Kipnis D. M. Abnormalities in carbohydrate tolerance associated with elevated plasma nonesterified fatty acids. J Clin Invest. 1965 Dec;44(12):2010–2020. doi: 10.1172/JCI105308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Schalch D. S. The influence of physical stress and exercise on growth hormone and insulin secretion in man. J Lab Clin Med. 1967 Feb;69(2):256–269. [PubMed] [Google Scholar]
  30. Tsushima T., Matsuzaki F., Irie M. Effect of heparin administration on plasma growth hormone concentrations. Proc Soc Exp Biol Med. 1970 Mar;133(3):1084–1087. doi: 10.3181/00379727-133-34629. [DOI] [PubMed] [Google Scholar]
  31. Tsushima T., Sakuma M., Irie M. Effect of changes in plasma free fatty acids level on secretion of human growth hormone. Endocrinol Jpn. 1970 Oct;17(5):369–377. doi: 10.1507/endocrj1954.17.369. [DOI] [PubMed] [Google Scholar]
  32. Yates F. E., Russell S. M., Maran J. W. Brain-adenohypophysial communication in mammals. Annu Rev Physiol. 1971;33:393–444. doi: 10.1146/annurev.ph.33.030171.002141. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES